Table 1.
Sociodemographic and clinical properties of patients
| Variable | Patient n (%) |
|---|---|
| Age at diagnosis | |
| 20–39 | 196 (24.1) |
| 40–49 | 258 (31.7) |
| 50–64 | 255 (31.4) |
| 65 ve üzeri | 104 (12.8) |
| Menopausal status | |
| Premenapausal | 471 (57.9) |
| Postmenapausal | 342 (42.1) |
| Histopathology | |
| Invasive ductal | 729 (89.6) |
| Invasive lobular | 40 (4.9) |
| Mucinous | 12 (1.5) |
| Mixed type | 12 (1.5) |
| Other | 20 (2.5) |
| Histologic Grade | |
| I | 43 (5.3) |
| II | 349 (42.9) |
| III | 360 (44.3) |
| Unknown | 61 (7.5) |
| Disease stage | |
| I | 32 (3.9) |
| II | 350 (43.1) |
| III | 362 (44.5) |
| IV | 69 (8.5) |
| ER status | |
| ER+ | 577 (71) |
| ER− | 227 (27.9) |
| Unknown | 9 (1.1) |
| PR status | |
| PR+ | 580 (71.3) |
| PR− | 221 (27.2) |
| Unknown | 12 (1.5) |
| HER2 status | |
| HER2+ | 259 (31.9) |
| HER2− | 544 (66.9) |
| Unknown | 10 (1.2) |
| Education level | |
| None | 388 (47.7) |
| Primary school | 268 (33) |
| Junior-high school | 48 (5.9) |
| High school | 63 (7.7) |
| University | 46 (5.7) |
| Residence | |
| Urban | 655 (80.6) |
| Rural | 158 (19.4) |
| Economya | |
| <500 TL | 186 (22.9) |
| 500–1500 TL | 309 (38) |
| >1500 TL | 318 (39.1) |
| Treatment type | |
| Surgery | 731 (89.7) |
| Chemotherapy | 695 (85.4) |
| Radiotherapy | 535 (65.8) |
| Hormonotherapy | 516 (63.4) |
a
Monthly family income level
ER: Estrogene receptor, PR: Progesteron receptor
HER2: Human epidermal growth factor receptor-2
n: Patient number